Cell proliferation was assessed using (3-(4,5 ... using a panel of antibodies covering the expression of chondrogenic marker (ACAN and COL2), angiogenesis marker (VEGF), angiogenesis inhibitor ...

We were the first lupus organization in the U.S. to support stromal cell research. In partnership with the National Institute of Allergy and Infectious Diseases, we committed nearly $4 million over ...

BMP9, a less-studied member of the BMP family, exhibits strong osteogenic effects on mesenchymal stem cells (MSCs ... been shown to activate osteogenic markers such as Runx2 and ALP in MSCs ...

Cells were analysed by flow cytometry using antibodies to mesenchymal stem cell markers CD90, CD73 and CD105, as well as qRT-PCR for stem cell and tenogenic markers. ECM components of the fibroblast ...

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers report. The aptamers -- short ...

As a start, the researchers observed primary Ad-MSCs and BM-MSCs to show the same morphology and cell-type specific markers as ... induced pluripotent stem cell-derived mesenchymal stromal cells ...

The tumors in these mice showed high expression of cancer stem cell markers CD56 and CD20 ... long non-coding RNA XIST to suppress epithelial-mesenchymal transition and stemness in breast cancer ...

Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that ...